HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adenosine deaminase enzyme therapy prevents and reverses the heightened cavernosal relaxation in priapism.

AbstractINTRODUCTION:
Priapism featured with painful prolonged penile erection is dangerous and commonly seen in sickle cell disease (SCD). The preventive approaches or effective treatment options for the disorder are limited because of poor understanding of its pathogenesis. Recent studies have revealed a novel role of excess adenosine in priapism caused by heightened cavernosal relaxation, and therefore present an intriguing mechanism-based therapeutic possibility.
AIM:
The aim of this study was to determine the therapeutic effects of adenosine deaminase (ADA) enzyme therapy to lower adenosine in priapism.
METHODS:
Both ADA-deficient mice and SCD transgenic (Tg) mice display priapism caused by excessive adenosine. Thus, we used these two distinct lines of mouse models of priapism as our investigative tools. Specifically, we treated both of these mice with different dosages of polyethylene glycol-modified ADA (PEG-ADA) to reduce adenosine levels in vivo. At the end points of the experiments, we evaluated the therapeutic effects of PEG-ADA treatment by measuring adenosine levels and monitoring the cavernosal relaxation.
MAIN OUTCOME MEASURES:
Adenosine levels in penile tissues were measured by high-performance liquid chromatography, and cavernosal relaxation was quantified by electrical field stimulation (EFS)-induced corporal cavernosal strip (CCS) assays.
RESULTS:
We found that lowering adenosine levels in penile tissues by PEG-ADA treatment from birth in ADA-deficient mice prevented the increased EFS-induced CCS relaxation associated with priapism. Intriguingly, in both ADA-deficient mice and SCD Tg mice with established priapism, we found that normalization of adenosine levels in penile tissues by PEG-ADA treatment relieved the heightened EFS-induced cavernosal relaxation in priapism.
CONCLUSIONS:
Our studies have identified that PEG-ADA is a novel, safe, and mechanism-based drug to prevent and correct excess adenosine-mediated increased cavernosal relaxation seen in two independent priapic animal models, and suggested its therapeutic possibility in men suffering from priapism.
AuthorsJiaming Wen, Xianzhen Jiang, Yingbo Dai, Yujin Zhang, Yuxin Tang, Hong Sun, Tiejuan Mi, Rodney E Kellems, Michael R Blackburn, Yang Xia
JournalThe journal of sexual medicine (J Sex Med) Vol. 7 Issue 9 Pg. 3011-22 (Sep 2010) ISSN: 1743-6109 [Electronic] Netherlands
PMID19845544 (Publication Type: Journal Article)
Copyright© 2009 International Society for Sexual Medicine.
Chemical References
  • Polyethylene Glycols
  • Adenosine Deaminase
Topics
  • Adenosine Deaminase (deficiency, metabolism, pharmacology)
  • Animals
  • Chromatography, High Pressure Liquid
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Electric Stimulation
  • Male
  • Mice
  • Mice, Knockout
  • Muscle Relaxation (drug effects)
  • Muscle, Smooth (drug effects)
  • Penis (enzymology, innervation)
  • Polyethylene Glycols
  • Priapism (drug therapy, enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: